(Q28193186)

inferred from title

placebo-controlled trial

1 reference

acute myocardial infarction

inferred from title

1 reference

Z M Chen

1

0 references

L X Jiang

2

0 references

Y P Chen

3

0 references

J X Xie

4

0 references

H C Pan

5

0 references

R Peto

6

0 references

R Collins

7

0 references

L S Liu

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

8

0 references

language of work or name

English

0 references

publication date

5 November 2005

0 references

published in

The Lancet

0 references

volume

366

0 references

issue

9497

0 references

page(s)

1607-21

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Ticlopidine and clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Ticlopidine and aspirin interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Clopidogrel as adjunctive antiplatelet therapy during coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

Early and late effects of clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967660-X

7 January 2021

10.1016/S0140-6736(05)67660-X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16271642

1 reference

Consolidated OpenCitations Corpus – April 2017